Τόμος 22 (2008) – Τεύχος 2 – Άρθρο 67 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 22 (2008) – Issue 2 – Article 67 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Hypolipidaemic and antioxidant properties of novel squalene synthase inhibitors
Authors A.  Matralis and Α. Κourounakis

Div. of Medicinal Chemistry, Dept. of Pharmacy, University of Athens, Greece

Citation Matralis, A., Kourounakis, A.: Hypolipidaemic and antioxidant properties of novel squalene synthase inhibitors, Epitheorese Klin. Farmakol. Farmakokinet. 22(2): 238-240 (2008)
Publication Date 23-25 May 2008
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)

pharmakonpress[at]pharmakonpress[.]gr

Keywords Squalene synthase inhibitor, hypercholesterolaemia, atherosclerosis, antioxidant compounds.
Other Terms Review article
Summary Elevated as well as oxidized levels of LDL-cholesterol and lipids in plasma are major factors in the pathogenesis of atherosclerosis. The aim of this study is the design and evaluation of new compounds for the treatment of atherosclerosis, that act on the multiple mechanisms involved in this disease. Towards this direction, new compounds that combine structural moieties with potential antihypercholesterolaemic, anti-hyperlipidaemic as well as antioxidant activity were synthesized and their activity was determined in vitro and in vivo. The six new derivatives were found to inhibit rat hepatic microsomal lipid peroxidation (IC50 = 650-170 μΜ) as well as the activity of squalene synthase (IC50 = 0.7-48 μΜ), the enzyme that catalyzes the first committed step towards cholesterol biosynthesis. Further, after administration to hyperlipidaemic rats, they reduced plasma levels of total cholesterol, LDL-cholesterol as well as triglycerides up to 80%. The combined activities of these compounds provide them with potential antiatherosclerotic activity.
References 1. Kourounakis et al.: submitted for publication

2. Tavridou A., et al.: Eur. J. Pharmacol. 535(1-3): 34-42 (2006)

3. Kourounakis A., et al.: Drug Development Res. 41: 9 (1999)

4. Chrysselis M., et al.: J. Med. Chem. 43: 609 (2000)

5. Pandit J.: J. Biol. Chem. 275: 30610 (2000)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2008 – ANNUAL SUBSCRIPTION 2008
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

 

 

Bookmark the permalink.

Comments are closed.